摘要
目的:探讨确认交叉配血实验有效性的方法,确保交叉配血实验结果的可控性,保证临床输血安全。方法:在交叉配血实验中用混合A细胞与IgG抗A血清的反应作为阳性对照、自身对照作为阴性对照,用阴阳性对照的实验结果对交叉配血结果是否有效进行确认。结果:所采用的对照物在2009-2011年的516例交叉配血实验中阳性对照均有效,5例阴性对照无效:其中2例由患者在治疗过程中使用肝素导致、1例为新生儿溶血病、2例为自身免疫性溶血性贫血。该5例自身对照出现无效的实验换用其他阴性对照后实验确认为有效;516例患者无一例输血事故发生。结论:在临床交叉配血实验中采用阳性、阴性对照对实验结果的有效性进行确认,可以杜绝实验差错,提高临床输血安全。
Objective:Explore confirm the effectiveness of the crossmatch blood experiment method,insure the controllability in crossmatch,so as to guarantee the safety in clinical transfusion. Method:To affirm the availability by comparison of experimental results form positive-negative-control and outcome from crossmatching.Positive control is by way of feedback from using mixed cell A and IgG anti-A serum in crossmatching of blood,while negative is by auto case-control. Result:The positive controls all remain in force in 516 samples of the adopted contrast in crossmatching between 2009-2011.Invalidation exists in 5 negative samples,including 2 samples are caused by using heparin during therapy,1 sample by hemolytic diseases of newborn,the other 2 are autoimmune hemolytic anemia.When changed to other negative-control,the invalid experiments of auto-case control from the 5 samples turn to valid indeed.No blood transfusion accident has happened of these 516 samples. Conclusion:It can eliminate error in experiments and enhance safety in clinical transfusion through the way of validity affirmation and quality control when adopting results form positive-negative-control in clinical crossmatching.
出处
《临床血液学杂志(输血与检验)》
CAS
2013年第3期368-369,共2页
Journal of Clinical Hematology(Blood Transfusion & Laboratory Medicine)
关键词
聚凝胺
交叉配血
有效性
polyacrylamide
crossmatching
validity